Quantum computing to accelerate research in the Health sector
Paris, Leverkusen, Aachen (GLOBE NEWSWIRE) - Atos, a global leader in digital transformation, Bayer, an international life science company, and RWTH Aachen University announce that they are working together to evaluate the use of Quantum Computing in research and analysis of human disease patterns. Computing and life science experts from these three institutions will use the Atos Quantum Learning Machine, the world's highest-performing quantum simulator, to research the evolution of multi-morbidity human diseases from large data repositories.
"Quantum Computing is one of the up and coming technologies that will have a game-changing impact on the life science industry, healthcare providers and of course treatment options for patients. While we consider it being early days for QC we want to make sure to learn how and in which areas it can best be used.", says Dirk Schapeler, VP G4A Digital Innovation from Bayer.
The project is based on anonymized real-world data of intensive care patients, to analyze and identify correlations between comorbidities and relevant patterns of disease evolution. This concept complements the approach of clinical trial studies that usually focuses on a limited number of patients and well-structured data to analyze disease criteria.
"We need to better understand the health state of patients with more than one disease. The Atos Quantum Learning machine will help us analyze the evolution of a disease and the interaction with comorbidities.", says Dr. Ulf Hengstmann, G4A Digital Health Innovation Manager from Bayer. "We already know that patients with specific diseases like heart failure can have several typical comorbidities. Now we need to understand why this is happening and how it affects therapy".
The Atos Quantum Learning Machine is the first industrialized and turnkey universal gate-based quantum system capable of simulating up to 41 Qubits (Quantum bits). It combines an ultra-compact system with a universal and standardized quantum programming language, AQASM (Atos Quantum Assembly Language). It also embeds a powerful software stack to simulate quantum programs on any quantum hardware including modelling of quantum noise, a unique feature on the market. Thanks to an in-memory based infrastructure, the computing simulation capacity can scale at any stage to support application scalability combined with higher workloads.
"Quantum computing is the next game-changer of the digital age", says Ursula Morgenstern, CEO of Atos Germany. "To unfold its full potential, customers need to develop and explore concrete use cases like Bayer is doing in this project".
The challenge for the coming years is to find applications which are able to run on early qubits quantum processors to demonstrate that quantum can either tackle problems that traditional computing cannot solve or prove that it is exponentially faster.
In parallel to the quantum computing approach, the Joint Research Center for Computational Biomedicine at RWTH Aachen University is running the analysis on a High Performance Computer (HPC) to evaluate the accuracy and performance of the quantum experiment results.
"Structural learning of mechanisms from massive data is a research focus of the Joint Research Center for Computational Biomedicine. The combination of quantum computing and machine learning is to a certain extent still a terra incognita where we see high potential in medical data analysis", says Professor Andreas Schuppert, Head of the JRC for Computational Biomedicine. "We are therefore creating comparative data analysis using HPC to evaluate its advantages in structural learning".
Atos is a global leader in digital transformation with 120,000 employees in 73 countries and annual revenue of € 13 billion. European number one in Cloud, Cybersecurity and High-Performance Computing, the Group provides end-to-end Orchestrated Hybrid Cloud, Big Data, Business Applications and Digital Workplace solutions through its Digital Transformation Factory, as well as transactional services through Worldline, the European leader in the payment industry. With its cutting-edge technologies and industry knowledge, Atos supports the digital transformation of its clients across all business sectors. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and operates under the brands Atos, Atos Syntel, Unify and Worldline. Atos is listed on the CAC40 Paris stock index.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of 35.0 billion euros. Capital expenditures amounted to 2.4 billion euros, R&D expenses to 4.5 billion euros. For more information, go to www.bayer.com.
About RWTH Aachen University
With 260 institutes in nine faculties, RWTH Aachen University is one of Europe's premier educational and research institutions. Currently, 45,000 students in 157 courses of study are enrolled at RWTH, including more than 9,500 international students from 131 countries. RWTH has succeeded in the Excellence Initiative of the federal and state governments and currently receives funding for its institutional strategy "Meeting Global Challenges," two Clusters of Excellence, and a graduate school. RWTH has established eight profile areaswhich reflect the interdisciplinary strengths of the University. With RWTH Aachen Campus, the University is creating a unique portfolio of services for collaboration in specialist clusters in which it is providing both expertise and a unique research infrastructure. With 19 research clusters on an 800,000 square meter site, RWTH Aachen Campus will be one of the largest technology-oriented research landscapes in Europe.
© 2018 GlobeNewswire, Inc. All Rights Reserved.
SOURCE: Atos International